These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1196 related articles for article (PubMed ID: 15913452)
1. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells. Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953 [TBL] [Abstract][Full Text] [Related]
3. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Sharrard RM; Maitland NJ Cell Signal; 2007 Jan; 19(1):129-38. PubMed ID: 16842970 [TBL] [Abstract][Full Text] [Related]
4. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863 [TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
6. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation. Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985 [TBL] [Abstract][Full Text] [Related]
7. Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells. Yang KJ; Piao L; Shin S; Shin SY; Li Y; Lee H; Tran Q; Park J; Hong S; Brazil DP; Hemmings BA; Kim SH; Park J Anticancer Res; 2017 Oct; 37(10):5415-5423. PubMed ID: 28982851 [TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337 [TBL] [Abstract][Full Text] [Related]
9. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Fang J; Ding M; Yang L; Liu LZ; Jiang BH Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033 [TBL] [Abstract][Full Text] [Related]
10. Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects. Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN Biol Psychiatry; 2010 Jun; 67(11):1017-25. PubMed ID: 20163786 [TBL] [Abstract][Full Text] [Related]
11. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867 [TBL] [Abstract][Full Text] [Related]
12. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779 [TBL] [Abstract][Full Text] [Related]
13. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732 [TBL] [Abstract][Full Text] [Related]